Skip to content

Clinical trials

Phase 3 Thrombocytopenia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 3 Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20033
20041
20062
20081
20092
20122
20132
20143
20161
20182
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated8
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Amgen2
CTI BioPharma2
Eisai Inc.2
M.D. Anderson Cancer Center2
Novartis Pharmaceuticals2
Pfizer2
Sobi, Inc.2
Carelon Research1
Hamilton Health Sciences Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia23
Purpura, Thrombocytopenic, Idiopathic6
Hematologic Diseases4
Purpura3
Anemia2
Blood Platelet Disorders2
Bone Marrow Diseases2
Hemorrhage2
Hemorrhagic Disorders2
Hepatitis C2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.